Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae

Table 4 Multivariate Models of risk factors for 30 days crude mortality in patients population (Forward Stepwise logistic regression)

	OR (CI 95%)	p-value
MODEL 1
KPC-K.pneumoniae BSI developing during inactive antibiotic treatment^a	28 (3.9 to 199)	0.001
Acute myeloid leukemia	Not included in the Model
Shock at onset	Not included in the Model
Intensive chemotherapy	Not included in the model
MODEL 2
Initial active treatment	0.019 (0.002 to 0.20)	0.001
KPC-K.pneumoniae BSI developing during inactive antibiotic treatment^a	Not included in the model
Acute myeloid leukemia	Not included in the model
Shock at onset	Not included in the model
Intensive chemotherapy	Not included in the model

^aDeveloping in KPC-K.pneumoniae carriers receiving standard empiric antibiotic treatment

ISSN: 1471-2334